NASDAQ
STTK

Shattuck Labs Inc

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Shattuck Labs Inc Stock Price

Vitals

Today's Low:
$2.1
Today's High:
$2.22
Open Price:
$2.22
52W Low:
$1.85
52W High:
$4.765
Prev. Close:
$2.19
Volume:
16568

Company Statistics

Market Cap.:
$93.01 million
Book Value:
3.26
Revenue TTM:
$859000
Operating Margin TTM:
-11165.66%
Gross Profit TTM:
$-82247000
Profit Margin:
0%
Return on Assets TTM:
-29.49%
Return on Equity TTM:
-51.04%

Company Profile

Shattuck Labs Inc had its IPO on 2020-10-09 under the ticker symbol STTK.

The company operates in the Healthcare sector and Biotechnology industry. Shattuck Labs Inc has a staff strength of 105 employees.

Stock update

Shares of Shattuck Labs Inc opened at $2.22 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.1 - $2.22, and closed at $2.1.

This is a -4.11% slip from the previous day's closing price.

A total volume of 16,568 shares were traded at the close of the day’s session.

In the last one week, shares of Shattuck Labs Inc have slipped by -6.67%.

Shattuck Labs Inc's Key Ratios

Shattuck Labs Inc has a market cap of $93.01 million, indicating a price to book ratio of 0.5314 and a price to sales ratio of 3.5349.

In the last 12-months Shattuck Labs Inc’s revenue was $859000 with a gross profit of $-82247000 and an EBITDA of $-91933000. The EBITDA ratio measures Shattuck Labs Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Shattuck Labs Inc’s operating margin was -11165.66% while its return on assets stood at -29.49% with a return of equity of -51.04%.

In Q2, Shattuck Labs Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 300%.

Shattuck Labs Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-2.12 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Shattuck Labs Inc’s profitability.

Shattuck Labs Inc stock is trading at a EV to sales ratio of 68.9414 and a EV to EBITDA ratio of 1.1448. Its price to sales ratio in the trailing 12-months stood at 3.5349.

Shattuck Labs Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$155.27 million
Total Liabilities
$12.99 million
Operating Cash Flow
$24.43 million
Capital Expenditure
$296000
Dividend Payout Ratio
0%

Shattuck Labs Inc ended 2024 with $155.27 million in total assets and $0 in total liabilities. Its intangible assets were valued at $155.27 million while shareholder equity stood at $138.46 million.

Shattuck Labs Inc ended 2024 with $0 in deferred long-term liabilities, $12.99 million in other current liabilities, 5000.00 in common stock, $-261082000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $71.89 million and cash and short-term investments were $117.17 million. The company’s total short-term debt was $747,000 while long-term debt stood at $0.

Shattuck Labs Inc’s total current assets stands at $136.45 million while long-term investments were $0 and short-term investments were $45.28 million. Its net receivables were $2.81 million compared to accounts payable of $2.01 million and inventory worth $0.

In 2024, Shattuck Labs Inc's operating cash flow was $24.43 million while its capital expenditure stood at $296000.

Comparatively, Shattuck Labs Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$2.1
52-Week High
$4.765
52-Week Low
$1.85
Analyst Target Price
$16

Shattuck Labs Inc stock is currently trading at $2.1 per share. It touched a 52-week high of $4.765 and a 52-week low of $4.765. Analysts tracking the stock have a 12-month average target price of $16.

Its 50-day moving average was $2.43 and 200-day moving average was $2.91 The short ratio stood at 18.3 indicating a short percent outstanding of 0%.

Around 1937.3% of the company’s stock are held by insiders while 4787.6% are held by institutions.

Frequently Asked Questions About Shattuck Labs Inc

The stock symbol (also called stock or share ticker) of Shattuck Labs Inc is STTK

The IPO of Shattuck Labs Inc took place on 2020-10-09

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
$54.69
0.58
+1.07%
HFCL Ltd (HFCL)
$71.4
-5.77
-7.48%
$1167.4
-65.1
-5.28%
BAMH (BAMH)
$18.56
0.03
+0.16%
$4.45
0
0%
$25.75
-0.4
-1.53%
$4.76
0.1
+2.15%
$1.62
-0.04
-2.17%
$3.82
-0.02
-0.52%
$1397.6
-20.65
-1.46%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company’s lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Address

500 West 5th Street, Austin, TX, United States, 78703